ライフサイエンスコーパス: social anxiety disorder

1 voxamine for the treatment of social phobia (social anxiety disorder).

2 en with BI do not go on to meet criteria for social anxiety disorder.

3 rs appear to be responsible for the onset of social anxiety disorder.

4 nical and clinical neurobiological models of social anxiety disorder.

5 .9% of subjects with noncomorbid generalized social anxiety disorder.

6 account for the known neurobiology of human social anxiety disorder.

7 for current generalized, separation, and/or social anxiety disorder.

8 cceptable and effective treatment option for social anxiety disorder.

9 ures for prediction of treatment response in social anxiety disorder.

10 irments such as autism spectrum disorder and social anxiety disorder.

11 to examine a gaze-contingent intervention in social anxiety disorder.

12 ularly those with a social component such as social anxiety disorder.

13 ng children are at marked risk of developing social anxiety disorder.

14 performance and social anxiety in women with social anxiety disorder.

15 ed the long-term outcome of psychotherapy in social anxiety disorder.

16 role in the pathophysiology and treatment of social anxiety disorder.

17 st intervention for the initial treatment of social anxiety disorder.

18 ive benefits for sertraline nonresponders in social anxiety disorder.

19 the neurodevelopmental mechanisms underlying social anxiety disorder.

20 ion with approved treatments for generalized social anxiety disorder.

21 for the acute management of the symptoms of social anxiety disorder.

22 ral therapy (CBT) in adults with generalized social anxiety disorder.

23 py (CBT) have been shown to be effective for social anxiety disorder.

24 gment a full course of comprehensive CBT for social anxiety disorder.

25 ht serve as biomarkers for interventions for social anxiety disorder.

26 s in developing preventive interventions for social anxiety disorder.

27 of behavioral inhibition are a precursor of social anxiety disorder.

28 on was associated with a lifetime history of social anxiety disorder.

29 disorder, and 6.2% (CI, 4.7% to 7.9%) had a social anxiety disorder.

30 rally well-tolerated treatment for pediatric social anxiety disorder.

31 ion that overlap with features of autism and social anxiety disorder.

32 -0.42) for GAD; 0.32 (95% CI: 0.29-0.37) for social anxiety disorder; 0.32 (95% CI: 0.23-0.42) for sp

33 anxiety disorder (6.2% lifetime prevalence), social anxiety disorder (13% lifetime prevalence), and p

34 Social anxiety disorder-a chronic and naturally unremitt

35 Our understanding of social anxiety disorder (also known as social phobia) ha

36 Subjects with social anxiety disorder and age- and gender-matched heal

37 ssociation between behavioral inhibition and social anxiety disorder and an inverse relationship betw

38 For social anxiety disorder and attention-deficit/hyperactiv

39 , 22 male, 1 transgender, 2 undeclared) with social anxiety disorder and fear of public speaking were

40 re, of interest, more frequently observed in social anxiety disorder and specific phobia than in PTSD

41 nce-avoidance gaze patterns in patients with social anxiety disorder and specific phobias.

42 sults support a conditioning contribution to social anxiety disorder and underscore the importance of

43 relevant to mental health disorders, such as social anxiety disorders and small animal phobias, that

44 g from emotion regulation disorders, such as social-anxiety disorder and psychopathy.

45 th introversion (a core personality trait in social anxiety disorder) and with increased limbic activ

46 vity in amygdala and insula in patients with social anxiety disorder, and genetic studies are increas

47 acotherapy for generalized anxiety disorder, social anxiety disorder, and panic disorder.

48 n in healthy participants, participants with social anxiety disorder, and participants with acute str

49 matching the biased content of rumination in social anxiety disorder, and robust to controlling for o

50 pressive disorder (MDD), panic disorder, and social anxiety disorder are among the most prevalent and

51 Separation, generalized, and social anxiety disorders are common and impairing for ch

52 e) and adolescents (12-17 years of age) with social anxiety disorder as their predominant psychiatric

53 disorder, posttraumatic stress disorder, and social anxiety disorder, as well as autism and schizophr

54 n, posttraumatic stress disorder, addiction, social anxiety disorder, bipolar disorder, schizophrenia

55 linical severity associated with generalized social anxiety disorder, both alone and with comorbid ps

56 ic therapy were both efficacious in treating social anxiety disorder, but there were significant diff

57 of behavioral inhibition are associated with social anxiety disorder by adolescence.

58 association of chronic high inhibition with social anxiety disorder by adolescence.

59 Primary search topics were social anxiety disorder, cognitive behavior therapy, and

60 vel gaze-contingent music reward therapy for social anxiety disorder designed to reduce attention dwe

61 Social anxiety disorder during adolescence or young adul

62 Patients with social anxiety disorder exhibit increased attentional dw

63 Adult outpatients with DSM-IV generalized social anxiety disorder for 6 months or longer were rand

64 ere included: posttraumatic stress disorder, social anxiety disorder, generalized anxiety disorder, p

65 Generalized social anxiety disorder (GSAD) is characterized by aberr

66 ty to threat in individuals with generalized social anxiety disorder (GSAD).

67 year, only 0.5% of subjects with generalized social anxiety disorder had been accurately diagnosed.

68 Persons with average-severity generalized social anxiety disorder had probabilities of graduating

69 ral inhibition, a temperamental precursor of social anxiety disorder (haplotype P = 3 x 10(-5); odds

70 [large effect size] [95% CI, 0.44 to 1.57]; social anxiety disorder: Hedges g = 0.41 [small to mediu

71 ta-analysis of interventions for adults with social anxiety disorder, identified from published and u

72 rmined the costs associated with generalized social anxiety disorder in a managed care setting.

73 efficacy of psychodynamic therapy and CBT in social anxiety disorder in a multicenter randomized cont

74 re most effective for the acute treatment of social anxiety disorder in adults.

75 e results suggest a grounding of symptoms of social anxiety disorder in more basic neuro-computationa

76 Social anxiety disorder in nondepressed persons at basel

77 dynamic therapy were efficacious in treating social anxiety disorder, in both the short- and long-ter

78 ncerning clinical neurobiological aspects of social anxiety disorder, including the developmental neu

79 Generalized anxiety disorder and social anxiety disorder interactomes showed exclusive an

80 Although social anxiety disorder is a common and sometimes disabl

81 Social anxiety disorder is a debilitating, highly preval

82 Social anxiety disorder is common and debilitating, and

83 Social anxiety disorder is common and impairing.

84 Social anxiety disorder is the most common anxiety disor

85 Social anxiety disorder is thought to involve emotional

86 The generalized type of social phobia (social anxiety disorder) is a severe and often disabling

87 cial phobia (gSP), also known as generalized social anxiety disorder, is characterized by excessive f

88 chizophrenia, and borderline personality and social anxiety disorders, may be reduced by oxytocin adm

89 -deficit/hyperactivity disorder (n = 1), and social anxiety disorder (n = 1).

90 medicated participants (N=22 generalized and social anxiety disorder/N=23 controls) recruited from Wa

91 169 medication-free adults with generalized social anxiety disorder, of whom 144 completed the 12-we

92 ugmentation strategy for exposure therapy in social anxiety disorder, one that may be especially effe

93 xiety disorder, separation anxiety disorder, social anxiety disorder, or anxiety disorder not otherwi

94 humans diagnosed as having specific phobia, social anxiety disorder, panic disorder with or without

95 isorder, selective mutism, specific phobias, social anxiety disorder, panic disorder, agoraphobia, an

96 disorders: major depressive disorder (MDD), social anxiety disorder, panic disorder, generalized anx

97 edged as an important etiologic mechanism in social anxiety disorder, past psychophysiological experi

98 the treatment of depression, panic disorder, social anxiety disorder, posttraumatic stress disorder,

99 ety disorder, obsessive-compulsive disorder, social anxiety disorder, posttraumatic stress disorder,

100 les, we examined how self-report symptoms of social anxiety disorder predict choices in a socially fr

101 pants were 105 treatment-seeking adults with social anxiety disorder, randomly allocated to 12 weeks

102 ne women 19-60 years of age with generalized social anxiety disorder received placebo intranasal spra

103 Social anxiety disorder (SAD) (also known as "social pho

104 Social anxiety disorder (SAD) can be adequately treated

105 Many patients with social anxiety disorder (SAD) experience inadequate symp

106 Only a minority of patients with social anxiety disorder (SAD) has a robust therapeutic r

107 Social anxiety disorder (SAD) is a crippling psychiatric

108 Social anxiety disorder (SAD) is a prevalent childhood-o

109 Social anxiety disorder (SAD) is characterized by fears

110 Social anxiety disorder (SAD) is common and debilitating

111 Cognitive models posit that social anxiety disorder (SAD) is maintained by biased in

112 Cognitive behavioral therapy (CBT) for social anxiety disorder (SAD) is thought to enhance cogn

113 Social anxiety disorder (SAD) places a profound burden o

114 Ninety-eight women meeting criteria for Social Anxiety Disorder (SAD) received two mindfulness s

115 nnectivity were measured in 38 patients with social anxiety disorder (SAD) to predict subsequent trea

116 ion (MBSR) are thought to help patients with social anxiety disorder (SAD) via distinct emotion-regul

117 fect, but whether anxiety syndromes, such as social anxiety disorder (SAD), are characterized by an o

118 abnormalities underlie pathological anxiety, social anxiety disorder (SAD)-although among the most co

119 ributing to the emergence and maintenance of social anxiety disorder (SAD).

120 ioral therapy (CBT) outcome in patients with social anxiety disorder (SAD).

121 into volumes of subcortical brain regions in social anxiety disorder (SAD).

122 losely mimics the key behavioral symptoms of social anxiety disorder (SAD).

123 treatment with JNJ-42165279 in subjects with social anxiety disorder (SAD).

124 g the characteristic negative memory bias in social anxiety disorder (SAD).

125 ly increases the risk for later diagnosis of social anxiety disorder (SAD).

126 n (SERT) and dopamine (DAT) in patients with social anxiety disorder (SAD).

127 measures poorly predict treatment outcome in social anxiety disorder (SAD).

128 rrelations) that discriminated patients with social anxiety disorder (SAD, N=16) from controls (N=19)

129 for adolescents (N = 133; 11-17 years) with social anxiety disorder (SAD; treatment) or subclinical

130 d better outcomes on self-report measures of social anxiety disorder severity (Liebowitz Social Anxie

131 Social anxiety disorder should be conceptualized as a ch

132 rence [SMD], -0.55 [95% CI, -0.64 to -0.46]; social anxiety disorder: SMD, -0.67 [95% CI, -0.76 to -0

133 Social anxiety disorder (social phobia or avoidant disor

134 ies of posttraumatic stress disorder (PTSD), social anxiety disorder, specific phobia, and fear condi

135 ety disorders: generalized anxiety disorder, social anxiety disorder, specific phobia, and panic diso

136 with confirmed diagnoses of panic disorder, social anxiety disorder, specific phobias, generalized a

137 disorder, generalized anxiety disorder, and social anxiety disorder, suggest that CRF1 receptor anta

138 a waiting list control condition in reducing social anxiety disorder symptoms.

139 py yielded greater reductions of symptoms of social anxiety disorder than the control condition on bo

140 ghted prevalence rate of current generalized social anxiety disorder was 8.2%.

141 Noncomorbid generalized social anxiety disorder was associated with significantl

142 community cohort of HMO members, generalized social anxiety disorder was rarely diagnosed or treated

143 Adults (n = 40) with a DSM-IV diagnosis of social anxiety disorder were randomized to placebo or yo

144 disorder, obsessive-compulsive disorder, or social anxiety disorder were randomly assigned by princi

145 METHOD: Forty patients with social anxiety disorder were randomly assigned to eight

146 In an outpatient setting, 495 patients with social anxiety disorder were randomly assigned to manual

147 A total of 45 patients with social anxiety disorder were scanned twice (11 weeks apa

148 ve outcomes for individuals with generalized social anxiety disorder who remain symptomatic after ini

149 Outpatients with social anxiety disorder who were treated with CBT (N=209

150 utilization of health services; generalized social anxiety disorder with comorbid psychopathology wa

151 e in the short-term treatment of generalized social anxiety disorder, with efficacy and tolerability

152 ort to assess the conditioning correlates of social anxiety disorder within an ecologically enhanced

153 and anxiety (n = 59), panic disorder and/or social anxiety disorder without comorbid MDD (n = 56), a

154 ment are the best-established treatments for social anxiety disorder, yet many individuals remain sym